Assurex Health announced that Virginia Coleman Drosos is the company's new president. Drosos comes to Assurex after 25 years at Procter & Gamble, where she held various positions. Most recently, she was group president for global beauty care at P&G.
Circulating tumor cell diagnostics developer Epic Sciences has appointed Murali Prahalad to be president and CEO.
Prahalad formerly held multiple posts at Life Technologies, and most recently he was VP of corporate strategies at the firm.
Before he joined Life Technologies, he was VP of business development at Sequenom, and he was a consultant for The Advisory Board Company and an analyst at Gemini Consulting in Tokyo.